- Home
- LXEH vs PTHL Comparison
LXEH vs PTHL Comparison
Compare LXEH & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEH
- PTHL
- Stock Information
- Founded
- LXEH 2001
- PTHL 1998
- Country
- LXEH China
- PTHL China
- Employees
- LXEH N/A
- PTHL N/A
- Industry
- LXEH Other Consumer Services
- PTHL
- Sector
- LXEH Real Estate
- PTHL
- Exchange
- LXEH Nasdaq
- PTHL Nasdaq
- Market Cap
- LXEH 12.5M
- PTHL 10.0M
- IPO Year
- LXEH 2020
- PTHL 2024
- Fundamental
- Price
- LXEH $0.37
- PTHL $0.64
- Analyst Decision
- LXEH
- PTHL
- Analyst Count
- LXEH 0
- PTHL 0
- Target Price
- LXEH N/A
- PTHL N/A
- AVG Volume (30 Days)
- LXEH 2.4M
- PTHL 112.7K
- Earning Date
- LXEH 09-26-2025
- PTHL 01-01-0001
- Dividend Yield
- LXEH N/A
- PTHL N/A
- EPS Growth
- LXEH N/A
- PTHL N/A
- EPS
- LXEH N/A
- PTHL N/A
- Revenue
- LXEH $4,585,942.00
- PTHL $448,196.00
- Revenue This Year
- LXEH N/A
- PTHL N/A
- Revenue Next Year
- LXEH N/A
- PTHL N/A
- P/E Ratio
- LXEH N/A
- PTHL N/A
- Revenue Growth
- LXEH N/A
- PTHL N/A
- 52 Week Low
- LXEH $0.31
- PTHL $0.51
- 52 Week High
- LXEH $50.08
- PTHL $32.00
- Technical
- Relative Strength Index (RSI)
- LXEH 22.81
- PTHL 32.11
- Support Level
- LXEH $0.31
- PTHL $0.55
- Resistance Level
- LXEH $0.38
- PTHL $0.70
- Average True Range (ATR)
- LXEH 0.28
- PTHL 0.06
- MACD
- LXEH -0.13
- PTHL 0.08
- Stochastic Oscillator
- LXEH 1.70
- PTHL 35.38
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.